Other Products

Discover our initiatives in various therapeutic areas

Valencin

Valencin® is used in adults and in children and adolescents (age from 1 to 17 years) to treat infections of the skin and the tissues below the skin. It is also used to treat infections in the blood when associated with skin infection.

also used in adults to treat infections in the tissues that line the inside of the heart (including heart valves) which are caused by a type of bacteria called Staphyloccocus aureus. also used to treat infections in the blood caused by the same type of bacteria when associated with heart infection.

Strength:

500 mg

Dosage Form:

Powder for solution for injection or infusion.

Active ingredient:

Daptomycin

Surlex

Surlex® is indicated for the reversal of neuromuscular blockade induced by specific muscle relaxants (rocuronium or vecuronium) in adults as well as paediatrics aged from 2-17 years old.

Strength:

100 mg

Dosage Form:

Vial for injection

Active ingredient:

Sugammadex

Zoledronic Acid SPC

Zoledronic Acid SPC® is indicated in adults for the treatment of Osteoporosis.

Strength:

5 mg/ 100 ml

Dosage Form:

Vial for injection

Active ingredient:

Zoledronic Acid Monohydrate

RENAPAT

RENAPAT® is indicated for the control of hyperphosphataemia in adult patients receiving haemodialysis, peritoneal dialysis or suffering from chronic kidney disease (CKD).

Strength:

800 mg

Dosage Form:

Film-Coated Tablets

Active ingredient:

Sevelamer Carbonate

Colistimethate SPC

Colistimethate SPC® is indicated for the treatment of serious infections caused by selected aerobic Gram-negative pathogens in patients with limited treatment options.

Strength:

1 million IU

Dosage Form:

Vial for injection

Active ingredient:

Colistimethate Sodium

Ruxaar

Ruxaar® can be used to treat Rheumatoid arthritis, sever and uncontrolled Psoriasis and a wide range of tumors, in particular:

  • acute leukemias,
  • Non-Hodgkin’s lymphoma,
  • soft tissue and bone sarcomas,
  • solid tumors like breast, lung, head and neck, bladder, cervical, ovarian and testicular cancer.

Strength:

2.5 mg

Dosage Form:

Tablet

Active ingredient:

Methotrexate

Fosaprepitant SPC

Fosaprepitant SPC® is indicated for the prevention of nausea and vomiting in patients receiving highly and moderately emetogenic cancer chemotherapy in adult as well as paediatric patients aged 6 months or older.

Strength:

150 mg

Dosage Form:

Vial for injection

Active ingredient:

Fosaprepitant